| 摘要 |
<p>The invention is concerned with novel pyridopyrimidinone derivatives of formula (I), wherein R1 to R8, X, Y, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds are HM74A agonists and can be used as medicaments.</p> |
